"Anticoagulants" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that prevent BLOOD CLOTTING.
| Descriptor ID |
D000925
|
| MeSH Number(s) |
D27.505.954.502.119
|
| Concept/Terms |
Anticoagulants- Anticoagulants
- Anticoagulation Agents
- Agents, Anticoagulation
- Anticoagulant Agents
- Agents, Anticoagulant
- Anticoagulant Drugs
- Drugs, Anticoagulant
- Anticoagulant
|
Below are MeSH descriptors whose meaning is more general than "Anticoagulants".
Below are MeSH descriptors whose meaning is more specific than "Anticoagulants".
This graph shows the total number of publications written about "Anticoagulants" by people in this website by year, and whether "Anticoagulants" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 1 | 1 | 2 |
| 2004 | 2 | 2 | 4 |
| 2005 | 2 | 2 | 4 |
| 2006 | 2 | 3 | 5 |
| 2007 | 3 | 4 | 7 |
| 2008 | 8 | 4 | 12 |
| 2009 | 9 | 1 | 10 |
| 2010 | 4 | 3 | 7 |
| 2011 | 5 | 2 | 7 |
| 2012 | 3 | 4 | 7 |
| 2013 | 3 | 3 | 6 |
| 2014 | 4 | 4 | 8 |
| 2015 | 10 | 2 | 12 |
| 2016 | 22 | 14 | 36 |
| 2017 | 258 | 123 | 381 |
| 2018 | 292 | 129 | 421 |
| 2019 | 89 | 77 | 166 |
| 2020 | 112 | 143 | 255 |
| 2021 | 60 | 90 | 150 |
| 2022 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Anticoagulants" by people in Profiles.
-
Thromboprophylaxis in Patients with COVID-19: Systematic Review of National and International Clinical Guidance Reports. Curr Vasc Pharmacol. 2022; 20(1):96-110.
-
Low molecular weight heparin is useful in adult COVID-19 inpatients. Experience during the first Spanish wave: observational study. Sao Paulo Med J. 2022 Jan-Feb; 140(1):123-133.
-
Pathomechanisms Underlying Hypoxemia in Two COVID-19-Associated Acute Respiratory Distress Syndrome Phenotypes: Insights From Thrombosis and Hemostasis. Shock. 2022 01 01; 57(1):1-6.
-
Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review. JAMA Cardiol. 2021 12 01; 6(12):1451-1460.
-
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients. Blood Adv. 2021 10 26; 5(20):3951-3959.
-
Prophylactic anticoagulants for people hospitalized with COVID-19: systematic review. Br J Surg. 2021 Sep 27; 108(9):e299-e300.
-
Nuts and bolts of COVID-19 associated coagulopathy: the essentials for management and treatment. Postgrad Med. 2021 Nov; 133(8):899-911.
-
Disruption of the biological activity of protease-activated receptors2/4 in adults rather than children in SARS CoV-2 virus-mediated mortality in COVID-19 infection. Drug Dev Res. 2021 12; 82(8):1075-1078.
-
Subcutaneous injection of mRNA vaccines against severe acute respiratory syndrome coronavirus 2: an option for severe bleeding disorders or anticoagulated patients? Blood Coagul Fibrinolysis. 2021 09 01; 32(6):423-424.
-
Impact of COVID-19 Infection on the Outcome of Patients With Ischemic Stroke. Stroke. 2021 12; 52(12):3908-3917.